Clinic
Community Health Service Agency,inc
Community Health Service Agency,inc was paid $22.28M by Medicaid between Jan 2018 and Dec 2024, across 122 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 67% of everything it billed.
33Billing provider infoCOMMUNITY HEALTH SERVICE AGENCY,INC
GREENVILLE, TX 75401
GREENVILLE, TX 75401
33aNPI1528041191assigned 11/28/2005
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$22.28M
24GClaims510,823
24DCodes billed122
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in Texas
Rank by total paid#10 of 248
Median peer was paid$796K
This provider vs. median28×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 786 | $94K | |
| 2019 | 876 | $85K | |
| 2020 | 23,874 | $1.01M | |
| 2021 | 123,497 | $5.24M | |
| 2022 | 135,346 | $5.79M | |
| 2023 | 125,002 | $5.42M | |
| 2024incomplete | 101,442 | $4.64M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 67% | 137,237 | 113,131 | $14.86M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.5% | 56,607 | 48,874 | $2.13M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.0% | 26,268 | 22,780 | $1.12M |
| D0999 | Unspecified diagnostic procedure, by report | 4.1% | 6,158 | 5,676 | $918K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.7% | 10,396 | 10,070 | $610K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.5% | 10,259 | 10,135 | $552K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.7% | 6,784 | 6,660 | $371K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.4% | 5,054 | 4,869 | $321K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 5,461 | 5,077 | $184K |
| 99381 | <1% | 2,192 | 2,123 | $140K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 2,489 | 2,386 | $114K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 2,060 | 1,866 | $112K |
110 more codes
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 16,404 | $92K |
| 59430 | <1% | 726 | $66K | |
| 99383 | <1% | 967 | $64K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 1,204 | $62K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | <1% | 94 | $54K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 870 | $48K |
| 99382 | <1% | 741 | $46K | |
| G0467 | Community health center visit, returning patient | <1% | 1,558 | $43K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,080 | $42K |
| 99000 | <1% | 22,715 | $42K | |
| 99384 | <1% | 677 | $41K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 1,944 | $30K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 437 | $20K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 8,622 | $18K |
| 90461 | <1% | 16,835 | $18K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 8,141 | $17K |
| 90620 | <1% | 940 | $17K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 506 | $16K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 544 | $15K |
| 90715 | <1% | 2,840 | $14K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 349 | $13K |
| 87428 | <1% | 2,838 | $9K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,275 | $8K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,253 | $7K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 117 | $6K |
| 81003 | <1% | 6,737 | $5K | |
| G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | <1% | 259 | $4K |
| 90686 | <1% | 6,009 | $3K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 14,171 | $3K |
| 90688 | <1% | 839 | $3K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 8,385 | $3K |
| 81002 | <1% | 4,042 | $2K | |
| 81025 | <1% | 2,962 | $2K | |
| 90619 | <1% | 117 | $2K | |
| 76801 | <1% | 43 | $2K | |
| 90677 | <1% | 1,836 | $2K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 404 | $1K |
| 99385 | <1% | 16 | $924.96 | |
| 90651 | <1% | 3,386 | $884.67 | |
| 90656 | <1% | 1,267 | $856.03 | |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 33 | $629.73 |
| 87807 | <1% | 106 | $627.00 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 14 | $607.13 |
| 90734 | <1% | 2,373 | $549.34 | |
| 86703 | <1% | 566 | $466.15 | |
| 92551 | <1% | 8,565 | $436.10 | |
| 0001A | <1% | 63 | $400.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 440 | $384.63 |
| 90670 | <1% | 5,688 | $356.82 | |
| 0071A | <1% | 117 | $280.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 58 | $278.96 |
| 90707 | <1% | 1,909 | $228.11 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 189 | $222.53 |
| 90681 | <1% | 2,283 | $203.62 | |
| 90710 | <1% | 2,011 | $203.62 | |
| 0002A | <1% | 31 | $160.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 210 | $153.99 |
| 0011A | <1% | 12 | $135.52 | |
| D1110 | Prophylaxis - adult | <1% | 494 | $109.76 |
| 87420 | <1% | 22 | $93.44 | |
| 90723 | <1% | 2,479 | $88.38 | |
| 85018 | <1% | 2,925 | $85.79 | |
| D0120 | Dental checkup, returning patient | <1% | 1,151 | $57.70 |
| 92587 | <1% | 578 | $53.60 | |
| 85610 | <1% | 46 | $50.40 | |
| D1206 | Topical application of fluoride varnish | <1% | 3,171 | $44.10 |
| 90662 | <1% | 12 | $40.00 | |
| D1120 | Dental cleaning, child | <1% | 2,546 | $36.75 |
| 82947 | <1% | 59 | $36.30 | |
| 93000 | <1% | 14 | $23.56 | |
| 84460 | <1% | 69 | $17.80 | |
| 84450 | <1% | 56 | $13.05 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 31 | $1.30 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 14 | $0.96 |
| S3620 | Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) | 0% | 689 | $0.00 |
| D0230 | Intraoral - periapical each additional radiographic image | 0% | 10,757 | $0.00 |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | 0% | 725 | $0.00 |
| D0603 | 0% | 4,551 | $0.00 | |
| D1351 | Sealant - per tooth | 0% | 1,223 | $0.00 |
| 90716 | 0% | 1,907 | $0.00 | |
| 90680 | 0% | 2,239 | $0.00 | |
| 91307 | 0% | 183 | $0.00 | |
| 90697 | 0% | 3,103 | $0.00 | |
| D0602 | 0% | 56 | $0.00 | |
| 90647 | 0% | 3,504 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 72 | $0.00 |
| D0150 | Comprehensive oral evaluation - new or established patient | 0% | 641 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 30 | $0.00 |
| 90698 | 0% | 379 | $0.00 | |
| 90696 | 0% | 1,738 | $0.00 | |
| 90744 | 0% | 14 | $0.00 | |
| 0072A | 0% | 33 | $0.00 | |
| 90381 | 0% | 40 | $0.00 | |
| 91301 | 0% | 87 | $0.00 | |
| 96158 | 0% | 382 | $0.00 | |
| 99173 | 0% | 7,058 | $0.00 | |
| D9230 | Inhalation of nitrous oxide / analgesia, anxiolysis | 0% | 943 | $0.00 |
| 90700 | 0% | 1,956 | $0.00 | |
| D0330 | Panoramic radiographic image | 0% | 454 | $0.00 |
| D0145 | Oral evaluation for a patient under three years of age | 0% | 1,072 | $0.00 |
| D0220 | Intraoral - periapical first radiographic image | 0% | 2,176 | $0.00 |
| D0274 | Bitewings - four radiographic images | 0% | 1,893 | $0.00 |
| 90633 | 0% | 4,011 | $0.00 | |
| 99490 | Ccm add 20min | 0% | 259 | $0.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 72 | $0.00 |
| 99177 | 0% | 3,672 | $0.00 | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | 0% | 223 | $0.00 |
| 90713 | 0% | 26 | $0.00 | |
| D0190 | 0% | 60 | $0.00 | |
| 91300 | 0% | 145 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCARTER, MICHELLE (CEO)
| Provider | Location | Paid |
|---|---|---|
| Community Health Service Agency, INC | Kaufman, TX | $194K |
| Community Health Service Agency, INC. | Sulphur Springs, TX | $143K |
| Community Health Service Agency, INC | Bonham, TX | $90K |
| Community Health Service Agency,inc | Greenville, TX | $70K |
| Community Health Service Agency, INC | Greenville, TX | $64K |
| Community Health Service Agency, INC. | Farmersville, TX | $58K |
| Community Health Service Agency INC | Greenville, TX | $787.50 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.